AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Aastrom Biosciences Inc (Aastrom) has formalized an agreement with Beth Israel Deaconess Medical Center (BIDMC), Boston, MA to conduct external clinical beta site evaluations of Aastrom's new DC-I dendritic cell product for use in vaccines to treat various forms of cancer.
Aastrom selected researchers at BIDMC as its second US collaborator …